NOREPINEPHRINE BITARTRATE INJECTION USP

generic medical partners inc🇨🇦 Health Canada

Approval Id: e615a7d2c456a6c5
Drug Approval Canada Name: NOREPINEPHRINE BITARTRATE INJECTION USP
Product Name: NOREPINEPHRINE BITARTRATE INJECTION USP
Status: Marketed
Status Date: 2020-05-04
Original Market Date: 2020-05-04
Din: 02485680
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 12:12.12
Atc Original: C01CA03 NOREPINEPHRINE
Atc Name: c 01 ca 03
Aig Number: 0131301001
Company Name: generic medical partners inc
Company Address: 1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4

NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

1 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e615a7d2c456a6c5

Type

Standard